UNSPSC 51162323: Acetaminophen/phenyltoloxamine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF) which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51162323 Acetaminophen/phenyltoloxamine is a Commodity code that in recent state and local solicitations covers parenteral pharmaceutical products, naloxone, and related medical supply provision to public health and correctional facilities. The Washington State Department of Corrections and Seminole County, Florida have posted opportunities reflecting the code's scope: the DOC solicitation (RFQQK13020, RFQ) seeks parenteral nutrition solutions, intravenous products, and controlled substances for eight correctional facilities across Washington, while the Seminole County solicitation (IFB60459723LAS, IFB) procures naloxone and drug deactivation systems for community health initiatives. State and local buyers under this code include corrections departments, county health departments, and other public health agencies. Issuing bodies source these products through both RFQ and IFB notice types, with multi-year contracts and periodic renewal options typical of the category.

Recent activity spans at least Washington state and Florida. The Washington State Department of Corrections RFQ (RFQQK13020), due October 7, 2026, anticipates selecting multiple contractors with up to three bidders per geographic region; the contract term runs November 26, 2026 through June 30, 2030 with fixed pricing for the initial two-year period. Contractors must meet Washington State business licensure and criminal clearance requirements, maintain specified insurance (Commercial General Liability, Professional Liability, Business Automobile Liability, and Cyber Liability), and demonstrate documented experience preparing and delivering IV solutions. The Seminole County IFB, posted June 30, 2026, procures 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the county community health building; that solicitation included set-aside targets for small businesses (25%), minority-owned businesses (10%), women-owned businesses (6%), and veteran-owned businesses (5%) under Washington State's Chapter 39.19 RCW, though the Florida solicitation does not specify disadvantaged-enterprise set-asides.